Zobrazeno 1 - 10
of 14
pro vyhledávání: '"M G, Muto"'
Autor:
Harvey J. Mamon, William K. Dahlberg, Edouard I. Azzam, M G Muto, Hatsumi Nagasawa, John B. Little
Publikováno v:
International journal of radiation biology. 79(10)
The ataxia-telangiectasia mutated (ATM) gene encodes a protein kinase, the activation of which is an early event in the cellular response to ionizing radiation. One of the many substrates of ATM is BRCA1 (breast cancer 1, early onset gene), which has
Autor:
B H, Ortiz, M, Ailawadi, C, Colitti, M G, Muto, M, Deavers, E G, Silva, R S, Berkowitz, S C, Mok, D M, Gershenson
Publikováno v:
Cancer research. 61(19)
The role of serous borderline ovarian tumors (BOTs) in the pathogenesis of serous ovarian carcinomas is unclear. Some authors have compared mutations in serous BOTs to those in serous ovarian carcinomas, but the data on two common oncogenes, p53 and
Autor:
J O, Schorge, M G, Muto, S J, Lee, L W, Huang, W R, Welch, D A, Bell, E Z, Keung, R S, Berkowitz, S C, Mok
Publikováno v:
Cancer research. 60(5)
Papillary serous carcinoma of the peritoneum (PSCP) is believed to develop de novo from the peritoneal lining of the pelvis and abdomen. Although it is histologically indistinguishable from serous ovarian carcinoma, PSCP exhibits minimal or absent ov
Publikováno v:
Obstetrics and gynecology. 92(4 Pt 1)
To compare BRCA1 mutations in papillary serous carcinoma of the peritoneum and papillary serous ovarian carcinoma.Germline DNA from 17 consecutive patients with peritoneal carcinoma was screened for mutations in the BRCA1 gene using single-strand con
Publikováno v:
Cancer research. 56(11)
To further define the genetic events that could lead to the development of borderline ovarian tumors (BOTs), we analyzed 13 microsatellite markers on chromosomes 3p and q in 18 BOTs and compared the results to 31 serous invasive epithelia] ovarian ca
Publikováno v:
Oncogene. 12(10)
Polymerase chain reaction (PCR) analysis of microsatellite polymorphisms corresponding to four loci which map to chromosome 17p and 11 loci which map to chromosome 17q was performed to screen for loss of heterozygosity (LOH) in paired normal and tumo
Publikováno v:
Cancer research. 56(6)
Among women of Ashkenazi Jewish origin, a frameshift mutation of the BRCA1 gene, designated 185delAG, occurs with a carrier frequency of approximately 1% and is estimated to account for about 39% of ovarian cancer cases occurring prior to age 50 year
Publikováno v:
Oncogene. 12(4)
Allelic deletions on chromosome 17q21 in sporadic ovarian cancer are common, suggesting that inactivation of a tumor suppressor gene(s) in that region may be important for the etiology of these tumors. The recently identified BRCA1 gene on 17q21, inv
Autor:
M G, Muto, A I, Kassis
Publikováno v:
Cancer. 76
Conventional therapy for epithelial ovarian cancer, including aggressive cytoreductive surgery followed by combination chemotherapy regimens, has failed to reduce the number of deaths caused by this disease, which remains the most lethal of gynecolog
Autor:
M G, Muto, W R, Welch, S C, Mok, C A, Bandera, P M, Fishbaugh, S W, Tsao, C C, Lau, H M, Goodman, R C, Knapp, R S, Berkowitz
Publikováno v:
Cancer research. 55(3)
Histopathological evidence suggests that papillary serous carcinoma of the peritoneum (PSCP) may be multifocal in origin. Utilizing a PCR based method to detect tandem repeat polymorphisms in formalin fixed tissue, loss of heterozygosity at eight loc